Cardinal ups F2025 outlook

 

• Revenue decreased 4% to $55.3 billion; revenue increased 16% excluding the impact of the previously communicated large customer contract expiration
• GAAP1 operating earnings were $549 million; GAAP diluted EPS was $1.65
• Non-GAAP operating earnings increased 9% to $635 million, driven by the Pharmaceutical and Specialty Solutions segment; non-GAAP diluted EPS increased 2% to $1.93
• Fiscal year 2025 non-GAAP EPS guidance2 raised to $7.85 to $8.00, from $7.75 to $7.90
• Company announces the completion of its acquisition of 73% ownership of GI Alliance

https://www.prnewswire.com/news-releases/cardinal-health-reports-second-quarter-fiscal-year-2025-results-and-raises-fiscal-year-2025-outlook-302364346.html